events
Abha Raveau-Violette | Trainer | Fleming
Linkedin

Abha Raveau-Violette

Abha Raveau-Violette is a regulatory, quality, and technical expert with over 17 years of experience specialising in drug-device combination products across the pharmaceutical and medical device industries.
She has held senior roles at AstraZeneca, Sandoz, and Teva supporting combination product development from early design through to global approval and lifecycle management, including FDA submissions and EU MDR Article 117 pathways.
Abha specialises in helping organisations avoid common failure points in combination product development, particularly in design controls, regulatory strategy, and the integration of drug and device requirements. She brings a practical, end-to-end perspective grounded in integrity and patient focus, helping ensure products are developed efficiently, compliantly, and with global market expectations in mind.
As founder of CPMD Consulting Ltd, she advises companies on navigating regulatory complexity and building successful combination product strategies from concept to commercialisation.

Events/Masterclasses Abha Raveau-Violette is currently speaking at

Pharma

Drug-Device Combination Products
20 - 21 October 2026
Basel, Switzerland | Online Live Stream
This intensive two-day course provides a practical, end-to-end framework for developing combination products from early strategy through design controls, regulatory submission, approval, and lifecycle management.
See Event

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

Contact us
view all trainers & speakers
view all events

REQUEST MORE INFORMATION

Linkedin
Abha Raveau-Violette
Job
Company
Abha Raveau-Violette is a regulatory, quality, and technical expert with over 17 years of experience specialising in drug-device combination products across the pharmaceutical and medical device industries.
She has held senior roles at AstraZeneca, Sandoz, and Teva supporting combination product development from early design through to global approval and lifecycle management, including FDA submissions and EU MDR Article 117 pathways.
Abha specialises in helping organisations avoid common failure points in combination product development, particularly in design controls, regulatory strategy, and the integration of drug and device requirements. She brings a practical, end-to-end perspective grounded in integrity and patient focus, helping ensure products are developed efficiently, compliantly, and with global market expectations in mind.
As founder of CPMD Consulting Ltd, she advises companies on navigating regulatory complexity and building successful combination product strategies from concept to commercialisation.
Abha Raveau-Violette
Description